Zelnorm Lawsuit Zelnorm
 
Zelnorm has been known to cause serious side effects such as stroke and heart attack. If you or a loved one have been injured by Zelnorm side effects you may be entitled to compensation.
Zelnorm News
Zelnorm Free Case Evaluation

Novartis will offer restricted Zelnorm for emergencies only

03 April 2008
Having restricted its use last year, Novartis has now served notice that it intends to take its irritable bowel syndrome off the US market completely.

The Swiss drugs giant has notified the US Food and Drug Administration that it will no longer provide Zelnorm (tegaserod maleate) as part of a restricted programme agreed with the agency in July last year. That agreement saw Novartis provide the drug to treat IBS with constipation and chronic idiopathic constipation in women younger than 55 who meet certain conditions.

However, the product was being treated as an investigational new drug and patients needed to meet strict criteria and have no known or pre-existing heart problems. Zelnorm, known elsewhere as Zelmac, had been off the US market for general use since March 2007 when Novartis suspended sales because a safety analysis found a higher chance of heart attack, stroke, and unstable angina in patients treated with Zelnorm compared with placebo.

Now the FDA reports that Novartis will only supply Zelnorm for use in emergency situations only and requests for the drug must be made to the agency which in turn would authorise shipment from the manufacturer. An emergency situation is defined as one that is “immediately life-threatening or serious enough to qualify for hospitalisation”.

However the FDA may still deny authorisation “if exposure to Zelnorm would pose an unreasonable or a significant additional risk to patients”. Conditions to stop the drug being prescribed include a history of heart problems, diabetes, smoking, obesity, and depression, and Zelnorm could also be denied to people aged over 55.

The loss of Zelnorm last year was a major blow for Novartis as the drug brought in $561 million in 2006, though first-half 2007 sales fell 66% to $91 million as the effect of the suspension kicked in. The company has not revealed why it has completely pulled the plug on the treatment.

 

If you or a loved one have experienced Zelnorm side effects such as severe chest pain, heart attack, or stroke you may be entitled to compensation. Contact the Zelnorm attorneys of Ennis & Ennis today for a free confidential case evaluation. Our on staff nurse and attorneys are standing by to answer any questions you may have regarding Zelnorm side effects, a possible Zelnorm class action lawsuit, or any other type of Zelnorm litigation.

Required fields in yellow*
 
Name:*
Email:*
Telephone: (123-123-1234)*
Mailing Address: *
City:*
State:*
Zip Code: *
 
On behalf of whom are you inquiring?
 
Is the person deceased?
Yes No
 
If the person is deceased please list the cause of death as listed on the death certificate:
 
Please list the dates that Zelnorm was used (MM/DD/YYYY):
to
 
Were there any medications taken with Zelnorm, if Yes, what were they?
 
Have you or the person you are inquiring on behalf of experienced any of the following side effects during or after treatment with Zelnorm? If yes, were you hospitalized?
Severe Angina:
Yes Yes, Hospitalized No
Heart Attack:
Yes Yes, Hospitalized No
Stroke:
Yes Yes, Hospitalized No
 
Is there a family history of any of the side effects listed above? If Yes, which ones?
 
If you have been diagnosed with any of the conditions above what date/dates were you diagnosed?
 
Please list any additional information you feel may be relevant to your potential Zelnorm side effects case:
 
   
Nationwide Free Case Evaluations: 1-800-856-6405